We are live on ! Find out more
ANAB icon

AnaptysBio

127 hedge funds and large institutions have $749M invested in AnaptysBio in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 42 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

124% more call options, than puts

Call options by funds: $673K | Put options by funds: $300K

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

4% more funds holding

Funds holding: 122127 (+5)

4% more capital invested

Capital invested by funds: $720M → $749M (+$28.4M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.88% less ownership

Funds ownership: 101.54%100.67% (-0.88%)

29% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 42

Holders
127
Holders Change
+5
Holders Change %
+4.1%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
15
Increased
30
Reduced
42
Closed
9
Calls
$673K
Puts
$300K
Net Calls
+$373K
Net Calls Change
+$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
Voloridge Investment Management
126
Voloridge Investment Management
Florida
-$1.17M -44,975 Closed
IC
127
Ikarian Capital
Texas
-$558K -21,553 Closed
E
128
Ergoteles
New York
-$296K -11,400 Closed
Tudor Investment Corp
129
Tudor Investment Corp
Connecticut
-$283K -10,902 Closed
KAM
130
Krensavage Asset Management
New York
-$282K -10,890 Closed
EGM
131
Engineers Gate Manager
New York
-$281K -10,840 Closed
Group One Trading
132
Group One Trading
Illinois
-$150K -5,920 Closed
FC
133
FORA Capital
Florida
-$66K -2,536 Closed
DFCM
134
Dark Forest Capital Management
Puerto Rico
-$61K -2,360 Closed

ANAB Hedge Fund Activity: Q3 2021 in Review

127 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q3 2021, worth a combined $749M — up 3.9% from $720M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ANAB positions and 9 closed out — a net gain of 6 holders — while 30 added to existing stakes and 42 trimmed.

The largest buyer was Woodline Partners, adding an estimated $12M. The largest seller was BVF Inc, cutting an estimated $12M.

  • 127 institutional investors held AnaptysBio (ANAB) as of Q3 2021, up from 122 in Q2 2021.
  • Funds reported $749M of AnaptysBio stock for Q3 2021, up 3.9% quarter-over-quarter.
  • 15 funds opened new AnaptysBio positions in Q3 2021 and 9 closed out, a net change of +6 holders.
  • The largest AnaptysBio buyer in Q3 2021 was Woodline Partners, an estimated $12M added.
  • The largest AnaptysBio seller in Q3 2021 was BVF Inc, an estimated $12M sold.

Based on aggregated 13F filings for Q3 2021.